Legend Biotech Corp. ADR (LEGN) Social Stream
LEGEND BIOTECH CORP (LEGN) Price Targets From Analysts
Use the tables below to see what analysts covering LEGEND BIOTECH CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 4 | $56 | $50 | $53 | $63.39 | -16.39% |
| 2021-11-19 | 4 | $61 | $51 | $55.75 | $63.39 | -12.05% |
| 2021-11-26 | 4 | $71 | $51 | $59.5 | $63.39 | -6.14% |
| 2022-01-06 | 5 | $71 | $51 | $60.8 | $63.39 | -4.09% |
| 2022-02-16 | 5 | $71 | $51 | $60.8 | $63.39 | -4.09% |
| 2022-03-01 | 5 | $73 | $51 | $62.4 | $63.39 | -1.56% |
| 2022-03-07 | 5 | $73 | $55 | $63.2 | $63.39 | -0.3% |
| 2022-04-19 | 6 | $73 | $53 | $61.5 | $63.39 | -2.98% |
| 2022-06-06 | 6 | $73 | $53 | $62.8 | $63.39 | -0.93% |
| 2022-06-17 | 6 | $77 | $53 | $65.166 | $63.39 | 2.8% |
| 2022-07-15 | 6 | $77 | $53 | $67.6 | $63.39 | 6.64% |
| 2022-10-04 | 6 | $77 | $53 | $66.5 | $63.39 | 4.91% |
| 2022-10-19 | 6 | $77 | $53 | $66 | $63.39 | 4.12% |
| 2022-11-29 | 9 | $77 | $53 | $66 | $63.39 | 4.12% |
| 2022-12-13 | 10 | $77 | $53 | $66.571 | $63.39 | 5.02% |
| 2023-01-05 | 10 | $78 | $53 | $67.428 | $63.39 | 6.37% |
| 2023-01-24 | 10 | $78 | $53 | $68.142 | $63.39 | 7.5% |
| 2023-01-25 | 10 | $78 | $65 | $69.857 | $63.39 | 10.2% |
| 2023-03-29 | 10 | $78 | $65 | $69.375 | $63.39 | 9.44% |
| 2023-04-03 | 11 | $78 | $65 | $69.375 | $63.39 | 9.44% |
| 2023-04-18 | 11 | $78 | $65 | $69.777 | $63.39 | 10.08% |
| 2023-04-20 | 12 | $85 | $65 | $73.5 | $63.39 | 15.95% |
| 2023-04-25 | 12 | $90 | $65 | $75.2 | $63.39 | 18.63% |
| 2023-05-18 | 13 | $90 | $65 | $75.2 | $63.39 | 18.63% |
| 2023-05-22 | 13 | $90 | $65 | $77.7 | $63.39 | 22.57% |
| 2023-05-25 | 15 | $90 | $64 | $77.363 | $63.39 | 22.04% |
| 2023-06-08 | 15 | $90 | $64 | $79.272 | $63.39 | 25.05% |
| 2023-06-13 | 14 | $90 | $64 | $79.7 | $63.39 | 25.73% |
| 2023-07-20 | 14 | $90 | $64 | $81.7 | $63.39 | 28.88% |
| 2023-07-21 | 14 | $93 | $64 | $83 | $63.39 | 30.94% |
| 2023-08-16 | 14 | $93 | $64 | $83.2 | $63.39 | 31.25% |
The Trend in the Analyst Price Target
Over the past 38 months, LEGN's average price target has gone up $32.53.
Over the past 45 weeks, LEGN's average upside potential has been 28.32%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-12 | 6 | 77 | 53 | 66.000 | 38.50 | 71.43% |
| 2023-01-25 | 9 | 78 | 65 | 69.857 | 53.25 | 31.19% |
| 2023-05-25 | 15 | 90 | 64 | 77.363 | 63.28 | 22.26% |
| 2023-06-08 | 15 | 90 | 64 | 79.272 | 68.91 | 15.04% |
| 2023-08-16 | 14 | 93 | 64 | 83.200 | 67.65 | 22.99% |
LEGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.36 | 11 | 1 | 2 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
LEGN's average broker recommendation rating worsened by 0.16 over the prior 16 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how LEGEND BIOTECH CORP fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 502.06% of that group.
- In terms of how LEGEND BIOTECH CORP fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -613.93% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, LEGEND BIOTECH CORP's average analyst price target is higher than 3209.8% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, LEGEND BIOTECH CORP's number of analysts covering the stock is greater than 1125.11% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LEGEND BIOTECH CORP are CVAC, QGEN, and SGEN.
View All Top Stocks by Price Target
Is LEGN a Buy, Hold or Sell? See the POWR Ratings now!